자동 봉합 기기 시장 - 세계 예측(2026-2032년)

The Automated Suturing Devices Market is projected to grow by USD 5.80 billion at a CAGR of 8.24% by 2032.

Automated suturing devices are reshaping wound closure across minimally invasive surgery, open surgery, bariatric procedures, gynecology, urology, cardiovascular care, and gastrointestinal interventions by improving procedural consistency and reducing dependence on manual knot tying in difficult anatomical locations. The category includes powered and mechanical suturing systems, endoscopic suturing platforms, disposable suturing instruments, reusable applicators, and related suture delivery technologies designed to support secure tissue approximation while helping surgeons work through smaller access points.

Demand is supported by well-documented healthcare priorities, including the global rise in surgical volume, the shift toward minimally invasive procedures, pressure to reduce operating room time, and the need to improve outcomes in complex wound closure. Health systems are also placing greater emphasis on standardizing surgical technique, reducing variability, and supporting clinicians as workforce constraints intensify. In this environment, automated suturing devices are moving from a specialized procedural aid toward an important element of advanced surgical workflows, particularly where precision, repeatability, and access limitations influence patient outcomes.

Transformative Shifts in the Automated Suturing Landscape

The automated suturing devices landscape is undergoing a structural transformation driven by minimally invasive surgery, robotics-assisted procedures, single-use device adoption, and the growing focus on ergonomics in the operating room. Laparoscopic and endoscopic interventions require suturing solutions that can function reliably in confined spaces, while clinicians seek devices that reduce hand fatigue, shorten learning curves, and provide consistent needle control. These needs are encouraging design improvements in articulation, reloadability, tissue handling, knot security, and compatibility with advanced imaging and access systems.

Regulatory and procurement expectations are also reshaping product development. Hospitals increasingly evaluate automated suturing devices not only on closure performance but also on sterilization requirements, ease of training, integration with existing surgical platforms, total procedural efficiency, and waste management considerations. At the same time, value-based care models are encouraging the adoption of technologies that can support fewer complications, faster recovery pathways, and improved reproducibility. The result is a shift from device-centric purchasing toward workflow-oriented surgical closure solutions that align clinical, operational, and economic objectives.

Cumulative Impact of Artificial Intelligence on Automated Suturing

Artificial intelligence is beginning to influence automated suturing devices through surgical planning, intraoperative decision support, robotic assistance, training analytics, and post-procedure performance evaluation. AI-enabled systems can support the interpretation of surgical video, tissue characteristics, instrument movement, and procedural patterns, helping clinicians identify opportunities to improve precision and reduce variation. In robotic and computer-assisted surgery, AI is expected to enhance suture path planning, tension control, needle positioning, and workflow guidance, particularly in complex minimally invasive procedures.

The cumulative impact of AI is also visible in surgeon education and quality improvement. Simulation platforms can analyze hand movements, needle angles, time to completion, and error patterns, enabling objective skills assessment for suturing tasks. Hospitals can use aggregated procedural data to refine protocols, standardize training, and identify best practices without relying solely on subjective evaluation. However, responsible adoption requires validated algorithms, transparent clinical evidence, cybersecurity safeguards, data governance, and compliance with medical device regulations. As AI matures, its role in automated suturing will likely be strongest where it improves safety, standardization, and procedural confidence rather than replacing surgical judgment.

Key Regional Insights Across Global Automated Suturing Adoption

Asia-Pacific is characterized by expanding surgical capacity, rising adoption of minimally invasive surgery, and large procedure volumes across China, India, Japan, South Korea, Australia, and ASEAN countries. Japan, South Korea, and Australia show strong alignment with advanced laparoscopic, robotic, and endoscopic procedures, while China and India are increasing access to specialized surgery through hospital infrastructure development, clinician training, and broader adoption of advanced operating room technologies. These conditions support stronger interest in automated suturing devices that improve consistency, tissue approximation, and procedural control in high-volume operating environments.

Europe demonstrates strong clinical governance, reimbursement scrutiny, and regulatory oversight under medical device frameworks, with Germany, France, Italy, Spain, and the United Kingdom showing demand for devices that support standardization and high-quality surgical outcomes. Hospitals in the region commonly prioritize clinical evidence, traceability, post-market surveillance, and training support, which encourages adoption of automated suturing technologies that can align with patient safety and value-based procurement expectations.

North America remains a highly innovation-oriented region, supported by established surgical centers, advanced hospital procurement systems, strong uptake of minimally invasive and robotic surgery, and rigorous regulatory standards. The United States and Canada emphasize clinical evidence, device safety, surgeon training, and operating room workflow efficiency, which encourages adoption of automated suturing technologies that can demonstrate practical procedural value in complex laparoscopic, endoscopic, bariatric, cardiovascular, and gastrointestinal surgery.

Latin America is progressing through modernization of surgical services, with Brazil and Mexico serving as important centers for advanced procedures. Adoption is influenced by hospital investment cycles, public-private healthcare differences, surgeon training access, and affordability considerations. The Middle East is advancing through investment in specialty hospitals, medical tourism, and tertiary care capacity, particularly across Gulf countries, where demand is tied to premium surgical capability and high-acuity care. Africa presents a more uneven landscape, where adoption is concentrated in private hospitals and major urban centers, while broader access depends on surgical workforce expansion, infrastructure, training, procurement financing, and cost-effective device pathways.

Key Group Insights for Automated Suturing Device Demand

NATO countries overlap significantly with advanced healthcare systems in North America and Europe while also including markets with varied defense, trauma, and emergency surgical readiness needs. These systems often emphasize reliable surgical technologies, standardized clinical training, resilient medical supply chains, and interoperability across hospital and field-care environments, supporting demand for automated suturing devices that can improve closure consistency and procedural efficiency.

G7 countries generally reflect high surgical standards, mature hospital networks, advanced minimally invasive procedure adoption, and strong regulatory oversight, making them important benchmarks for clinical evidence, physician training, and technology diffusion in automated suturing. The European Union is defined by harmonized medical device regulation, robust clinical evaluation requirements, and procurement systems that prioritize safety, traceability, and evidence-based adoption. This favors automated suturing devices with strong documentation, quality systems, post-market surveillance readiness, and comprehensive user training support.

BRICS economies combine large patient populations, growing surgical volumes, and expanding domestic healthcare capacity, creating strong long-term relevance for automated suturing solutions, although adoption patterns vary by reimbursement, infrastructure, domestic manufacturing priorities, and procurement processes. ASEAN countries are increasingly relevant as surgical infrastructure expands across major urban hospitals and regional medical hubs, with adoption shaped by growing minimally invasive surgery programs, public healthcare investments, private hospital networks, and clinician training needs. The GCC is strengthening demand through investments in advanced hospitals, specialty surgical centers, and medical tourism strategies, with high-acuity care environments receptive to automated suturing technologies that support complex procedures, efficiency, and premium surgical capability.

Key Country Insights in Automated Suturing Devices

China is expanding advanced surgical capacity rapidly through hospital investment, specialist training, and growing use of minimally invasive techniques, supporting demand for automated suturing devices that improve procedural consistency in high-volume care settings. The United States is a leading environment for automated suturing device adoption due to high procedural complexity, established minimally invasive surgery programs, robotic surgery integration, and strong emphasis on clinical evidence and operating room efficiency. Japan has a mature surgical ecosystem with strong focus on precision, quality, and aging-related procedural needs, while India presents significant demand potential due to high surgical volume, expanding private healthcare, and increasing laparoscopic adoption, with cost-effective and training-friendly devices gaining importance.

Germany's strong hospital infrastructure and surgical specialization support demand for high-performance suturing technologies, and the United Kingdom emphasizes health technology assessment, surgical productivity, and outcomes-based adoption. Australia combines advanced clinical standards with structured procurement and strong adoption of minimally invasive approaches, while France maintains a regulated, quality-driven adoption environment shaped by clinical evidence and hospital purchasing discipline. South Korea is recognized for sophisticated hospital systems, digital health readiness, and high uptake of advanced surgical techniques, supporting continued interest in automated suturing platforms that enhance procedural precision.

Italy and Spain demonstrate interest in minimally invasive solutions that improve procedural efficiency across public and private systems, while Canada follows a quality-focused pathway influenced by public healthcare procurement, surgical wait-time management, and evidence-based technology assessment. Russia's adoption is shaped by regional healthcare modernization, domestic supply considerations, and access to advanced surgical technologies. Brazil and Mexico show growing relevance through private hospital networks, medical tourism, and expanding advanced surgical capabilities, although access, reimbursement, procurement budgets, and affordability remain important adoption factors.

Actionable Recommendations for Automated Suturing Industry Leaders

Industry leaders should prioritize clinical validation, surgeon-centered design, and workflow integration to strengthen adoption of automated suturing devices. Product development should focus on consistent tissue approximation, intuitive handling, reliable needle control, ergonomic efficiency, and compatibility with laparoscopic, endoscopic, and robotic environments. Training is equally critical; structured simulation, proctoring, and competency-based education can reduce learning curves and improve confidence among surgeons and operating room teams.

Commercial strategies should align with evidence-based procurement by demonstrating measurable procedural benefits such as improved consistency, reduced technical variability, shorter closure steps, and compatibility with enhanced recovery pathways. Manufacturers and distributors should also address sterilization logistics, single-use waste concerns, supply reliability, and total cost of use. In emerging markets, success will depend on adaptable pricing models, local training partnerships, and devices that balance performance with affordability. For AI-enabled suturing technologies, leaders must invest in transparent validation, cybersecurity, human oversight, and regulatory compliance from the earliest stages of development.

Research Methodology for Evidence-Based Market Insight

This executive summary is developed using a structured secondary research approach focused on verified healthcare, regulatory, clinical, and technology sources. The methodology includes analysis of publicly available medical device regulations, surgical society guidance, hospital technology adoption patterns, peer-reviewed literature on minimally invasive surgery and suturing techniques, public health data on surgical care access, and documented trends in robotic and digital surgery. Insights are synthesized to identify demand drivers, adoption barriers, regional dynamics, and technology shifts relevant to automated suturing devices.

The research approach avoids speculative market sizing, revenue estimation, market share ranking, and forecasting. Instead, it emphasizes evidence-backed qualitative assessment, including regulatory environments, procedural trends, infrastructure readiness, clinical workflow needs, and training requirements. Regional, group, and country insights are interpreted through healthcare system maturity, surgical capacity, procurement behavior, and innovation adoption patterns to provide a reliable strategic view of the automated suturing devices landscape.

Conclusion on the Future of Automated Suturing Devices

Automated suturing devices are becoming increasingly important as surgical care shifts toward minimally invasive, standardized, and efficiency-driven procedures. Their value is strongest where access is limited, tissue handling is complex, and consistent closure quality is essential. Advances in robotics, digital surgery, device ergonomics, and AI-enabled analytics are expanding the strategic role of automated suturing from a procedural tool to a broader component of surgical performance improvement.

Future adoption will depend on validated clinical outcomes, practical workflow benefits, effective surgeon training, regulatory compliance, and affordability across diverse healthcare systems. Regions with mature surgical infrastructure will continue to emphasize evidence, integration, and precision, while emerging markets will prioritize access, training, and cost-effective performance. Industry participants that combine clinical credibility with user-focused innovation and responsible digital integration will be best positioned to support the next phase of automated suturing device adoption.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Automated Suturing Devices Market, by Product Type

• 7.1. Introduction
• 7.2. Disposable Devices
• 7.3. Reusable Devices

8. Automated Suturing Devices Market, by Technology

• 8.1. Introduction
• 8.2. Electrosurgical
  • 8.2.1. Bipolar
  • 8.2.2. Ultrasonic
• 8.3. Mechanical
  • 8.3.1. Compression Clip
  • 8.3.2. Stapling Mechanism

9. Automated Suturing Devices Market, by Suture Material

• 9.1. Introduction
• 9.2. Absorbable
• 9.3. Non-absorbable

10. Automated Suturing Devices Market, by Automation Level

• 10.1. Introduction
• 10.2. Fully Automatic
• 10.3. Semi-automatic

11. Automated Suturing Devices Market, by Application

• 11.1. Introduction
• 11.2. Cardiovascular Surgery
• 11.3. Colorectal Surgery
• 11.4. General Surgery
• 11.5. Gynecological Surgery
• 11.6. Orthopedic Surgery

12. Automated Suturing Devices Market, by End User

• 12.1. Introduction
• 12.2. Ambulatory Surgical Centers
• 12.3. Hospitals
• 12.4. Specialty Clinics

13. Automated Suturing Devices Market, by Region

• 13.1. Asia-Pacific
• 13.2. Europe
• 13.3. North America
• 13.4. Latin America
• 13.5. Africa
• 13.6. Middle East

14. Automated Suturing Devices Market, by Group

• 14.1. NATO
• 14.2. G7
• 14.3. BRICS
• 14.4. European Union
• 14.5. ASEAN
• 14.6. GCC

15. Automated Suturing Devices Market, by Country

• 15.1. China
• 15.2. United States
• 15.3. Japan
• 15.4. India
• 15.5. Germany
• 15.6. United Kingdom
• 15.7. Australia
• 15.8. France
• 15.9. South Korea
• 15.10. Italy
• 15.11. Canada
• 15.12. Russia
• 15.13. Brazil
• 15.14. Mexico
• 15.15. Spain

16. Competitive Landscape

• 16.1. Market Share Analysis, 2025
• 16.2. FPNV Positioning Matrix, 2025
• 16.3. Market Concentration Analysis, 2025
  • 16.3.1. Concentration Ratio (CR)
  • 16.3.2. Herfindahl Hirschman Index (HHI)
• 16.4. Recent Developments & Impact Analysis, 2025
• 16.5. Product Portfolio Analysis, 2025
• 16.6. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. 3M Company
• 17.2. B. Braun Melsungen AG
• 17.3. Baxter International Inc.
• 17.4. Boston Scientific Corporation
• 17.5. Coloplast A/S
• 17.6. ConMed Corporation
• 17.7. Corza Medical, Inc.
• 17.8. DEMCON holding B.V.
• 17.9. DemeTECH Corporation
• 17.10. Ethicon, Inc.
• 17.11. Frankenman International Limited
• 17.12. Healthium Medtech Limited
• 17.13. Intuitive Surgical, Inc.
• 17.14. Karl Storz SE & Co. KG
• 17.15. Medtronic plc
• 17.16. Mellon Medical B.V.
• 17.17. Olympus Corporation
• 17.18. Peters Surgical, Inc.
• 17.19. Smith & Nephew plc
• 17.20. Surgical Innovations Ltd
• 17.21. Sutrue Limited
• 17.22. SuturTek, Inc.
• 17.23. TELA Bio, Inc.
• 17.24. Teleflex Incorporated
• 17.25. Teleflex, Inc.
• 17.26. Zimmer Biomet Holdings, Inc.